Financial Performance Overview
United Imaging Healthcare (SSE: 688271), a premier name in advanced medical imaging and radiotherapy, has released an impressive annual report, showcasing remarkable financial results. For 2024, the company reported a significant revenue of CNY 10.30 billion. Coupled with this, net income attributable to shareholders also saw a remarkable boost, hitting CNY 1.26 billion.
First Quarter Insights
Continuing the trend, United Imaging Healthcare shared its financial results for the first quarter of 2025. This report indicated that Q1 2025 revenue reached CNY 2.48 billion, with net income for shareholders amounting to CNY 0.37 billion. This represents a year-over-year increase of 5.42% in revenue and a 1.87% rise in net income, underscoring the company's growth trajectory.
Commitment to Innovation
In a bid to enhance its product lineup, United Imaging Healthcare committed significant resources to research and development, devoting CNY 2.26 billion to R&D in 2024. This dedication led to the introduction of over 140 innovative products on a global scale. Notably, 49 of these received clearance from the U.S. FDA through the 510(k) process, and 46 were certified by CE under MDR/MDD. Among the highlights is the uMI Panorama series, which successfully achieved CE certification, and the uMR Jupiter, recognized as the world’s sole whole-body clinical ultra-high-field MRI system to gain NMPA, FDA, and CE approvals.
AI Innovations in Radiology
The surge of artificial intelligence in healthcare is evident, especially within the radiology sector, which is identified as the most AI-intensive segment. United Imaging Healthcare has emerged as a leader in this domain, boasting over 20 AI-powered devices that have gained FDA approval. This innovation position solidifies their reputation as a pioneer in integrating AI into medical imaging.
A Growing Global Presence
United Imaging Healthcare has strategically expanded its global footprint, developing robust sales and service networks across both established and emerging markets. The company now operates in over 85 countries and regions, with a strong presence in more than 200 cities worldwide. This expansive reach is facilitated by a well-structured service network comprising 7 regional spare parts hubs and 32 national warehouses. This strategic endeavor saw overseas revenue jumping to CNY 2.27 billion in 2025, reflecting a year-over-year growth of 35.07%.
Expansion in Europe
In Europe, United Imaging Healthcare established its European headquarters in Rotterdam, launching commercial operations throughout the five largest Western European economies. Their systems, including the light-guide digital PET/CT, were successfully installed in notable medical centers such as France's EVESIO Nuclear Medical Center and Germany's Kliniken Essen-Mitte Evang. The company achieved significant market penetration across more than half of the 27 EU member states, consolidating its position in 15 plus countries.
Advancements in North America
In North America, the impact of United Imaging's full suite of imaging products is notable, covering over 70% of U.S. state-level administrative regions. With over 100 PET/CT installations, the systems are embraced by leading clinical and research institutions. Noteworthy adopters include Yale University, Akumin, the University of California, Davis, and Washington University School of Medicine.
Growth in Asia-Pacific
The Asia-Pacific region is witnessing strong growth, driven by strategic market penetration in both developed nations like Japan and South Korea, as well as emerging markets such as India. United Imaging has solidified its market share and made significant advancements in strategically important regions including Turkey, Mexico, and Brazil, completing several system installations in these rapidly expanding markets.
Future Outlook
As United Imaging Healthcare looks to the future, the focus remains on fostering healthcare advancements through continual innovation. The company's dedication is aimed at developing state-of-the-art technologies that enhance clinical outcomes and broaden access to quality healthcare for patients globally.
Frequently Asked Questions
What financial results did United Imaging Healthcare report for 2024?
United Imaging Healthcare reported a revenue of CNY 10.30 billion and a net income of CNY 1.26 billion for 2024.
How has United Imaging Healthcare invested in innovation?
The company invested CNY 2.26 billion in R&D, launching over 140 innovative products globally in 2024.
What is United Imaging's position in AI medical devices?
United Imaging Healthcare leads with over 20 FDA-approved AI-powered devices in the radiology segment.
How extensive is United Imaging Healthcare's global presence?
The company operates in over 85 countries and serves over 200 cities worldwide.
What future plans does United Imaging Healthcare have?
United Imaging is focused on continuous innovation and developing technologies to improve healthcare access and clinical outcomes worldwide.
